|
CN103709150A
|
|
A besigliptin tosilate crystal form, a preparation method there and applications thereof
|
|
CN103709147A
|
|
Flumatinib mesylate crystal form, preparation method thereof and applications thereof
|
|
CN103709149A
|
|
A besigliptin tosilate crystal form, a preparation method there and applications thereof
|
|
CN102813908A
|
|
Lyophilization technology for preparing bivalirudin for injection
|
|
CN103030609A
|
|
Method for preparing repaglinide
|
|
CN102816146A
|
|
Flumatinib mesylate crystal form A and preparation method and use thereof
|
|
CN102816208A
|
|
Liquid phase synthesis method of bivalirudin
|
|
CN102816147A
|
|
Flumatinib mesylate crystal form B and preparation method and use thereof
|
|
CN102796079A
|
|
Method for preparing flumatinib mesylate
|
|
CN102796117A
|
|
Method for preparing cefcapene pivoxil hydrochloride
|
|
CN102796065A
|
|
Method for preparing high-optical-purity escitalopram
|
|
CN102786498A
|
|
Method for preparing repaglinide
|
